Travel Food Services Gets Bullish Nod As ICICI Securities Initiates 'Buy'
ICICI Securities has initiated coverage on Travel Food Services Ltd. with a ‘Buy' rating and a target price of Rs 1,600, citing a strong structural growth story in the travel food and lounge segment.
The company operates in the travel quick-service restaurants space and lounge sectors in airports across places. It has over 425 travel QSR outlets and over 35 airport lounges spread across travel hubs. Notably, the company is backed by K Hospitality which operates and invests in renowned brands and business verticals such as Copper Chimney, Bombay Brasserie, Blue Sea Catering and Banquets, and LifeCo Services
The brokerage noted;
Superior execution to further consolidate TFS' leading position in travel QSR and lounge business
Expect scale to improve its ability to win future concessions at other airports
Should deliver strong profitability of 38% and RoCE of over 25%, over FY26-28E
The company's travel QSR portfolio offers a variety of cuisines and concepts, ranging from fast food, cafes, and bakeries to restaurants and bars. The company specifically caters to travellers' demands for speed and convenience within travel hubs, it said on its website. TFS manages a portfolio of over 100 brands, including international names like KFC, Jamie Oliver's Kitchen, and Brioche Dorée, alongside its own in-house brands.
Meanwhile, the company's umbrella brand for lounge business is named 'ARAYA'. The company primarily operates quick-service restaurants and airport lounges at airports in India, Malaysia, and Hong Kong.
Travel Food Services is a fairly newly losted company with its shares debuting on BSE, NSE on Jul 14, 2025. The stock has gained over 18% ever since its listing on the benchmark indices in recent months.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.